PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1466178
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1466178
India Cancer Treatment Market, By Treatment Type; By Drug Type; By Cancer Type; By End User; By Region, Trend Analysis, Competitive Landscape & Forecast, 2019-2030
India Cancer Treatment Market Size Expanding at Significant CAGR of 8% to Touch USD 5.9 Billion by 2030
India Cancer Treatment Market is growing due to the rising burden of cancer, growing awareness about cancer, government's initiatives to improve cancer care, and growing adoption of advanced technologies.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the India Cancer Treatment Market size by value at USD 4.21 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the India Cancer Treatment Market size to expand at a CAGR of 8% reaching a value of USD 5.89 billion by 2030. The Cancer Treatment Market in India is propelled by increasing rate of cancer cases, with an estimated 1.39 million cases in 2020 and over 0.8 million deaths in 2019, posing a significant public health concern. Notably, cervical cancer claims one woman's life every 8 minutes, and breast cancer mortality remains high. The surge in tobacco consumption further exacerbates cancer fatalities. Factors contributing to rising cases include dietary changes, food adulteration, and environmental factors. Sedentary lifestyles and junk food consumption also contribute to increasing cancer incidences. It underscores the pressing need for timely diagnosis and preventive care, driving substantial investments in R&D to develop more effective drugs. The Indian market offers growth opportunities for venture capitalists and investors, given the saturation of developed markets in the cancer treatment industry.
Opportunity - Increasing Popularity for Ayurveda-based Cancer Medication and Therapies
The Indian government has undertaken various initiatives to promote research in Ayurveda and the advancement of cancer treatments. The Central Council for Research in Ayurvedic Sciences (CCRAS), an independent organization established by the government, has been actively engaged in cancer research, drug development, and documenting medical procedures. AYUSH QOL2C, developed by CCRAS, aims to improve the quality of life for cancer patients. Consequently, Ayurveda-based medications are poised to offer promising opportunities for industry players during the forecast period.
Impact of Escalating Geopolitical Tensions on India Cancer Treatment Market
Geopolitical tensions can have a multifaceted impact on the India Cancer Treatment Market. Uncertainties arising from geopolitical conflicts may disrupt the supply chain of crucial medical equipment, drugs, and resources necessary for cancer treatment. Additionally, heightened tensions may lead to economic instability, affecting healthcare budgets and investment in medical infrastructure and research. Import restrictions and trade barriers resulting from geopolitical conflicts can further exacerbate the situation, limiting access to essential cancer treatment technologies and medications. Overall, escalating geopolitical tensions pose significant challenges to the India Cancer Treatment Market, potentially impeding access to vital healthcare services for cancer patients.
India Cancer Treatment Market
Segmental Coverage
India Cancer Treatment Market - By Cancer Type
On the basis of cancer type, the India Cancer Treatment Market is divided into Blood Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Non-Hodgkin's Cancer, and Respiratory/ Lung Cancer segments. The breast cancer segment holds the highest share in the India Cancer Treatment Market by cancer type. Breast cancer stands as a prevalent global and Indian health concern, exacerbated by insufficient awareness. Oncologists emphasize the importance of cancer literacy, particularly among women aged 40 to 60, advocating for regular screening to enable early detection and effective treatment. Meanwhile, the cervical cancer holds the highest share in the India Cancer Treatment Market by cancer type. It often linked to Human Papillomavirus (HPV) infection, affects 12% of Indian women, while oral cancer constitutes 7% of annual new cancer diagnoses. This underscores the necessity for heightened awareness campaigns and proactive screening initiatives to combat the rising incidence rates of these cancers and ensure timely interventions for improved patient outcomes.
Competitive Landscape
The India Cancer Treatment Market is fragmented, with numerous players serving the market. The key players dominating the India Cancer Treatment Market include Bayer, Astellas Pharma Inc., F. Hoffmann-La-Roche, Pfizer Limited, Natco Pharma, Novartis AG, Amgen, Merck KGaA, Siemens Healthineers, Bristol-Myers Squibb Company, Pinnacle Life Science Pvt. Ltd, and Takeda Pharmaceuticals. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.
The report's in-depth analysis provides information about growth potential, upcoming trends, and the India Cancer Treatment Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the India Cancer Treatment Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.
Table of Contents
1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
2. Executive Summary
3. India Cancer Treatment Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Rising burden of cancer
- 3.2.1.2. Increasing awareness about cancer in India
- 3.2.1.3. Government initiatives to improve cancer care in the country
- 3.2.1.4. Growing adoption of advanced technologies
- 3.2.2. Restraints
- 3.2.2.1. High cost of treatment
- 3.2.2.2. Lack of infrastructure
- 3.2.2.3. Shortage of skilled healthcare professionals
- 3.2.3. Opportunities
- 3.2.3.1. Increasing popularity for Ayurveda-based cancer medication and therapies
- 3.2.3.2. Growing demand for affordable cancer care solutions in India.
- 3.2.3.3. Growing healthcare insurance
- 3.2.4. Challenges
- 3.2.4.1. Presence of Counterfeit drugs:
- 3.2.4.2. Lack of awareness about early detection
- 3.2.1. Growth Drivers
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
4. India Cancer Treatment Market: Pricing Analysis
5. India Cancer Treatment Market: Marketing Strategies
6. India Cancer Treatment Market Overview
- 6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Billion)
- 6.2. Market Share & Forecast
- 6.2.1. By Treatment Type
- 6.2.1.1. Chemotherapy
- 6.2.1.2. Targeted Therapy
- 6.2.1.3. Immunotherapy
- 6.2.1.4. Hormonal Therapy
- 6.2.1.5. Others
- 6.2.2. By Drug Type
- 6.2.2.1. Cytotoxic Drugs
- 6.2.2.2. Targeted Drugs
- 6.2.2.3. Hormonal Drugs
- 6.2.2.4. Others
- 6.2.3. By Cancer Type
- 6.2.3.1. Blood Cancer
- 6.2.3.2. Breast Cancer
- 6.2.3.3. Colorectal Cancer
- 6.2.3.4. Cervical Cancer
- 6.2.3.5. Prostate Cancer
- 6.2.3.6. Gastrointestinal Cancer
- 6.2.3.7. Gynecologic Cancer
- 6.2.3.8. Non-Hodgkin's Cancer
- 6.2.3.9. Respiratory/ Lung Cancer
- 6.2.3.10. Others
- 6.2.4. By End User
- 6.2.4.1. Hospitals
- 6.2.4.2. Specialty Clinics
- 6.2.4.3. Cancer and Radiation Therapy Centers
- 6.2.5. By Region
- 6.2.5.1. North India
- 6.2.5.2. South India
- 6.2.5.3. East India
- 6.2.5.4. West India
- 6.2.1. By Treatment Type
7. North India Cancer Treatment Market
- 7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Billion)
- 7.2. Market Share & Forecast
- 7.2.1. By Treatment Type
- 7.2.2. By Drug Type
- 7.2.3. By Cancer Type
- 7.2.4. By End User
8. South India Cancer Treatment Market
- 8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Billion)
- 8.2. Market Share & Forecast
- 8.2.1. By Treatment Type
- 8.2.2. By Drug Type
- 8.2.3. By Cancer Type
- 8.2.4. By End User
9. East India Cancer Treatment Market
- 9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Billion)
- 9.2. Market Share & Forecast
- 9.2.1. By Treatment Type
- 9.2.2. By Drug Type
- 9.2.3. By Cancer Type
- 9.2.4. By End User
10. West India Cancer Treatment Market
- 10.1. Market Size & Forecast, 2019-2030
- 10.1.1. By Value (USD Billion)
- 10.2. Market Share & Forecast
- 10.2.1. By Treatment Type
- 10.2.2. By Drug Type
- 10.2.3. By Cancer Type
- 10.2.4. By End User
11. Competitive Landscape
- 11.1. List of Key Players and Their Offerings
- 11.2. India Cancer Treatment Company Market Share Analysis, 2023
- 11.3. Competitive Benchmarking, By Operation Channel Parameters
- 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
12. Impact of Escalating Geopolitical Tensions in India Cancer Treatment Market
13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 13.1. Bayer
- 13.2. Astellas Pharma Inc.,
- 13.3. F. Hoffmann- La- Roche
- 13.4. Pfizer Limited
- 13.5. Natco Pharma
- 13.6. Novartis AG
- 13.7. Amgen
- 13.8. Merck KGaA
- 13.9. Siemens Healthineers
- 13.10. Bristol-Myers Squibb Company
- 13.11. Pinnacle Life Science Pvt Ltd
- 13.12. Takeda Pharmaceuticals
- 13.13. Other Prominent Players
14. Key Strategic Recommendations
15. Research Methodology
- 15.1. Qualitative Research
- 15.1.1. Primary & Secondary Research
- 15.2. Quantitative Research
- 15.3. Market Breakdown & Data Triangulation
- 15.3.1. Secondary Research
- 15.3.2. Primary Research
- 15.4. Breakdown of Primary Research Respondents, By Region
- 15.5. Assumption & Limitation
*Financial information of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
- Figure 1 India Cancer Treatment Market Segmentation
- Figure 2 India Cancer Treatment Market Value Chain Analysis
- Figure 3 Company Market Share Analysis, 2023
- Figure 4 India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Figure 5 India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Figure 6 India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Figure 7 India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Figure 8 India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
- Figure 9 India Cancer Treatment Market Share, By Region, By Value (USD Billion) 2019-2030
- Figure 10 North India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Figure 11 North India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Figure 12 North India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Figure 13 North India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Figure 14 North India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
- Figure 15 South India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Figure 16 South India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Figure 17 South India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Figure 18 South India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Figure 19 South India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
- Figure 20 East India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Figure 21 East India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Figure 22 East India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Figure 23 East India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Figure 24 East India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
- Figure 25 West India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Figure 26 West India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Figure 27 West India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Figure 28 West India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Figure 29 West India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
List of Tables
- Table 1 India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Table 2 India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Table 3 India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Table 4 India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Table 5 India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
- Table 6 India Cancer Treatment Market Share, By Region, By Value (USD Billion) 2019-2030
- Table 7 North India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Table 8 North India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Table 9 North India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Table 10 North India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Table 11 North India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
- Table 12 South India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Table 13 South India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Table 14 South India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Table 15 South India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Table 16 South India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
- Table 17 East India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Table 18 East India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Table 19 East India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Table 20 East India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Table 21 East India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
- Table 22 West India Cancer Treatment Market Size, By Value (USD Billion), 2019-2030
- Table 23 West India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019-2030
- Table 24 West India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019-2030
- Table 25 West India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019-2030
- Table 26 West India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019-2030
- Table 27 Bayer Company Overview
- Table 28 Bayer Company Overview
- Table 29 Astellas Pharma Inc., Company Overview
- Table 30 Astellas Pharma Inc., Company Overview
- Table 31 F. Hoffmann- La- Roche Company Overview
- Table 32 F. Hoffmann- La- Roche Company Overview
- Table 33 Pfizer Limited Company Overview
- Table 34 Pfizer Limited Company Overview
- Table 35 Natco Pharma Company Overview
- Table 36 Natco Pharma Company Overview
- Table 37 Novartis AG Company Overview
- Table 38 Novartis AG Company Overview
- Table 39 Amgen Company Overview
- Table 40 Amgen Company Overview
- Table 41 Merck KGaA Company Overview
- Table 42 Merck KGaA Company Overview
- Table 43 Siemens Healthineers Company Overview
- Table 44 Siemens Healthineers Company Overview
- Table 45 Bristol-Myers Squibb Company Overview
- Table 46 Bristol-Myers Squibb Company Overview
- Table 47 Pinnacle Life Science Pvt Ltd Company Overview
- Table 48 Pinnacle Life Science Pvt Ltd Company Overview
- Table 49 Takeda Pharmaceuticals Company Overview
- Table 50 Takeda Pharmaceuticals Company Overview
